Christopher Davis
Clipper Fund
Christopher Davis CVS Health Corp stake
total: 58
Clipper Fund CVS trades
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2024 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q1 report, Christopher Davis holds 781,360 CVS Health Corp (CVS) shares with a market value of roughly $56.12M accounting for 4.20% of the overall portfolio. To date, the estimated cost basis is nearly $44.89 for "buy" trades. Clipper Fund first purchased CVS in 2024 Q4, initially acquiring 781,360 shares.
When did Christopher Davis buy CVS Health Corp (CVS)?
Christopher Davis first invested in CVS Health Corp (CVS) in 2024 Q4 at the reported quarter-end price of $44.89 per share.
What's the cost basis of Clipper Fund's CVS stake?
The estimated cost basis for CVS Health Corp (CVS) stake is around $44.89 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $44.89
Christopher Davis's historical trades in CVS Health Corp
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
3.05%
|
781,360
|
$44.89
|
$35,075,250
|
new
|
+3.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.